Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped
Good news for Hims & Hers stock spooks Lilly and Novo investors.
Investors are buying Hims & Hers Health (NYSE: HIMS) stock hand over fist after the mail-order drugs company reported an earnings miss but a sales beat last night. But they're selling off shares of Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the latter of which is a Hims & Hers partner now.
As of 11:20 a.m. ET, Hims & Hers stock is surging to 11.2% and beyond, whereas both Eli Lilly and Novo Nordisk stocks are down 3.2%.
Image source: Getty Images.
